Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL)
NCT00464633
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
165
Enrollment
INDUSTRY
Sponsor class
Conditions
Leukemia, Lymphocytic, Chronic
Interventions
DRUG:
alvocidib
Sponsor
Sanofi